Several previous studies have however shown that the expression of predictive tissue markers including ERα, PR and HER2 may differ between the primary breast tumor and solid distant metastases (“receptor conversion”) in a significant proportion of patients [12–14]. Here, ESR1 is linked to breast neoplasm.